Literature DB >> 18367011

Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia.

Babbette D LaMarca1, Michael J Ryan, Jeffrey S Gilbert, Sydney R Murphy, Joey P Granger.   

Abstract

Reduced uterine perfusion pressure during pregnancy is an important initiating event in preeclampsia. Inflammatory cytokines are thought to link placental ischemia with cardiovascular and renal dysfunction. Supporting a role for cytokines are findings of elevated tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 plasma levels in preeclamptic women. Blood pressure regulatory systems (eg, renin-angiotensin system [RAS] and sympathetic nervous system) interact with proinflammatory cytokines, which affect angiogenic and endothelium-derived factors regulating endothelial function. Chronic reductions in placental perfusion in pregnant rats are associated with enhanced TNF-alpha and IL-6 production. Chronic infusion of TNF-alpha or 11-6 into normal pregnant rats significantly increases arterial pressure and impairs renal hemodynamics. TNF-alpha activates the endothelin system in placental, renal, and vascular tissues, and IL-6 stimulates the RAS. These findings suggest that inflammatory cytokines elevate blood pressure during pregnancy by activating multiple neurohumoral and endothelial factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18367011     DOI: 10.1007/s11906-007-0088-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  37 in total

Review 1.  Hypertension during pregnancy: a disorder begging for pathophysiological support.

Authors:  Ravi I Thadhani; Richard J Johnson; S Ananth Karumanchi
Journal:  Hypertension       Date:  2005-10-24       Impact factor: 10.190

Review 2.  Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question.

Authors:  S Ananth Karumanchi; Yuval Bdolah
Journal:  Endocrinology       Date:  2004-11       Impact factor: 4.736

3.  Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.

Authors:  A Rajakumar; H M Michael; P A Rajakumar; E Shibata; C A Hubel; S Ananth Karumanchi; R Thadhani; M Wolf; G Harger; N Markovic
Journal:  Placenta       Date:  2005-08       Impact factor: 3.481

4.  Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.

Authors:  Carl A Hubel; Gerd Wallukat; Myles Wolf; Florian Herse; Augustine Rajakumar; James M Roberts; Nina Markovic; Ravi Thadhani; Friedrich C Luft; Ralf Dechend
Journal:  Hypertension       Date:  2007-01-08       Impact factor: 10.190

5.  Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis.

Authors:  A Hara; T Wada; K Furuichi; N Sakai; H Kawachi; F Shimizu; M Shibuya; K Matsushima; H Yokoyama; K Egashira; S Kaneko
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

6.  Angiotensin II hypertension is attenuated in interleukin-6 knockout mice.

Authors:  Dexter L Lee; Lashon C Sturgis; Hicham Labazi; James B Osborne; Cassandra Fleming; Jennifer S Pollock; Marlina Manhiani; John D Imig; Michael W Brands
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-11-11       Impact factor: 4.733

7.  Interleukin-1beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure.

Authors:  S Ye; P Mozayeni; M Gamburd; H Zhong; V M Campese
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

8.  Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature.

Authors:  Thomas Walther; Gerd Wallukat; Alexander Jank; Sabine Bartel; Heinz-Peter Schultheiss; Renaldo Faber; Holger Stepan
Journal:  Hypertension       Date:  2005-10-31       Impact factor: 10.190

9.  Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.

Authors:  Cissy Chenyi Zhou; Shakil Ahmad; TieJuan Mi; Lingwei Xia; Shahrzad Abbasi; Peter W Hewett; ChunXiao Sun; Asif Ahmed; Rodney E Kellems; Yang Xia
Journal:  Circ Res       Date:  2006-12-07       Impact factor: 17.367

10.  Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.

Authors:  Myles Wolf; Anand Shah; Chun Lam; Abelardo Martinez; Karen V Smirnakis; Franklin H Epstein; Robert N Taylor; Jeffrey L Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  Am J Obstet Gynecol       Date:  2005-07       Impact factor: 8.661

View more
  90 in total

1.  17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Authors:  Lorena M Amaral; Denise C Cornelius; Ashlyn Harmon; Janae Moseley; James N Martin; Babbette LaMarca
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.

Authors:  Ossama M Reslan; Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-10-01

3.  Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor.

Authors:  Kathleen Mayor-Lynn; Tannaz Toloubeydokhti; Amelia C Cruz; Nasser Chegini
Journal:  Reprod Sci       Date:  2010-11-15       Impact factor: 3.060

4.  Hypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 system.

Authors:  Kedra Wallace; Sarah Novotny; Judith Heath; Janae Moseley; James N Martin; Michelle Y Owens; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-05-30       Impact factor: 3.619

5.  Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.

Authors:  Lorena M Amaral; Jessica L Faulkner; Jamil Elfarra; Denise C Cornelius; Mark W Cunningham; Tarek Ibrahim; Venkata Ramana Vaka; Jessica McKenzie; Babbette LaMarca
Journal:  Hypertension       Date:  2017-10-30       Impact factor: 10.190

6.  Interleukin-4 supplementation improves the pathophysiology of hypertension in response to placental ischemia in RUPP rats.

Authors:  Jesse N Cottrell; Lorena M Amaral; Ashlyn Harmon; Denise C Cornelius; Mark W Cunningham; Venkata Ramana Vaka; Tarek Ibrahim; Florian Herse; Gerd Wallukat; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-01-09       Impact factor: 3.619

7.  Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection.

Authors:  Luis M Gomez; Lauren Anton; Shindu K Srinivas; Michal A Elovitz; Samuel Parry
Journal:  Reprod Sci       Date:  2018-12-20       Impact factor: 3.060

8.  Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells.

Authors:  Bhavisha A Bakrania; Frank T Spradley; Simon C Satchell; David E Stec; John M Rimoldi; Rama S V Gadepalli; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-12-06       Impact factor: 3.619

Review 9.  Investigating Maternal Brain Alterations in Preeclampsia: the Need for a Multidisciplinary Effort.

Authors:  Lina Bergman; Pablo Torres-Vergara; Jeffrey Penny; Johan Wikström; Maria Nelander; Jose Leon; Mary Tolcher; James M Roberts; Anna-Karin Wikström; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2019-08-02       Impact factor: 5.369

10.  Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Authors:  Alaa Amash; Gershon Holcberg; Olga Sapir; Mahmoud Huleihel
Journal:  J Interferon Cytokine Res       Date:  2012-08-21       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.